Endurant Capital Management’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,922
Closed -$227K 20
2023
Q4
$227K Buy
+4,922
New +$209K 1.3% 22
2023
Q3
Sell
-59,137
Closed -$2.82M 54
2023
Q2
$2.82M Sell
59,137
-109,570
-65% -$5.28M 2.47% 14
2023
Q1
$8.22M Buy
168,707
+130,278
+339% +$6.63M 4.22% 6
2022
Q4
$2.03M Sell
38,429
-248,192
-87% -$12.2M 0.83% 24
2022
Q3
$12.5M Sell
286,621
-88,924
-24% -$4.39M 4.09% 6
2022
Q2
$18.8M Buy
375,545
+323,058
+616% +$15.8M 6.59% 2
2022
Q1
$2.73M Buy
+52,487
New +$2.71M 0.72% 32
2018
Q2
Sell
-19,333
Closed -$662K 76
2018
Q1
$662K Buy
+19,333
New +$679K 0.25% 61

Other funds holding QGEN

Endurant Capital Management's QGEN Position: Q1 2024 in Review

Endurant Capital Management sold out of Qiagen (QGEN) in Q1 2024, closing a stake of 4,922 shares — an estimated $227K sold.

Endurant Capital Management first reported a position in QGEN in Q1 2018 and held it in 8 quarters. The position peaked at $18.8M in Q2 2022. 282 funds tracked by Wall St. Rank hold QGEN as of Q1 2024.

  • Endurant Capital Management reported no remaining Qiagen position as of Q1 2024 after selling out during the quarter.
  • Endurant Capital Management sold 4,922 Qiagen shares in Q1 2024, an estimated $227K.
  • Endurant Capital Management first reported a position in Qiagen in Q1 2018 and held it in 8 quarters.
  • Endurant Capital Management's Qiagen position peaked at $18.8M in Q2 2022.
  • 282 funds tracked by Wall St. Rank held Qiagen as of Q1 2024.

Based on Endurant Capital Management's 13F filing for Q1 2024.